You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BKZ

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis Trial (Placebo, Bimekizumab)

Not yet recruiting
  • Chronic Plaque Psoriasis
  • Moderate to Severe Chronic Plaque Psoriasis
  • (no location specified)
Aug 21, 2023

Healthy Study Participants Trial in Glendale, Berlin (bimekizumab)

Active, not recruiting
  • Healthy Study Participants
  • Glendale, California
  • +1 more
Sep 20, 2022

Healthy Volunteers Trial in Harrow (Bimekizumab)

Completed
  • Healthy Volunteers
  • Harrow, United Kingdom
    (unnamed)
Aug 25, 2021

Moderate to Severe Plaque Psoriasis Trial in Worldwide (bimekizumab)

Active, not recruiting
  • Moderate to Severe Plaque Psoriasis
  • Indianapolis, Indiana
  • +10 more
Aug 19, 2022

Moderate to Severe Plaque Psoriasis Trial in Korea, Republic of (bimekizumab, Placebo)

Active, not recruiting
  • Moderate to Severe Plaque Psoriasis
  • Bucheon-si, Korea, Republic of
  • +8 more
Jul 28, 2022

Healthy Study Participants Trial in Berlin (Bimekizumab)

Terminated
  • Healthy Study Participants
  • Berlin, Germany
    Up0068 001
Aug 12, 2021

Healthy Volunteers Trial in San Antonio (Bimekizumab)

Completed
  • Healthy Volunteers
  • San Antonio, Texas
    Up0034 001
Sep 16, 2020

Healthy Volunteers Trial in Baltimore, Berlin (Bimekizumab)

Completed
  • Healthy Volunteers
  • Baltimore, Maryland
  • +1 more
Jun 12, 2020

Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis Trial in Worldwide (Bimekizumab, Secukinumab, Placebo)

Active, not recruiting
Has Results
  • Chronic Plaque Psoriasis
  • Moderate to Severe Chronic Plaque Psoriasis
  • Santa Ana, California
  • +76 more
Jan 25, 2023

Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis Trial in Canada, United States (Bimekizumab)

Completed
  • Chronic Plaque Psoriasis
  • Moderate to Severe Chronic Plaque Psoriasis
  • Phoenix, Arizona
  • +38 more
Jan 6, 2022

Nonradiographic Axial Spondyloarthritis Trial in Worldwide (Bimekizumab, Placebo)

Active, not recruiting
  • Nonradiographic Axial Spondyloarthritis
  • Mesa, Arizona
  • +82 more
Aug 23, 2022

Axial Spondyloarthritis, Ankylosing Spondylitis, r-axSpa Trial in Worldwide (Bimekizumab)

Enrolling by invitation
  • Axial Spondyloarthritis
  • +2 more
  • Glendale, Arizona
  • +72 more
Mar 24, 2022

Chronic Plaque Psoriasis Trial in Worldwide (Bimekizumab)

Completed
Has Results
  • Chronic Plaque Psoriasis
  • High Point, North Carolina
  • +9 more
Mar 3, 2022

Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriatic Arthritis Trial in Worldwide (Bimekizumab,

Completed
Has Results
  • Chronic Plaque Psoriasis
  • +2 more
  • Phoenix, Arizona
  • +104 more
Jul 15, 2022

Psoriatic Arthritis Trial in Worldwide (Bimekizumab, Placebo)

Completed
  • Psoriatic Arthritis
  • Phoenix, Arizona
  • +92 more
Mar 14, 2022

Psoriatic Arthritis Trial in Worldwide (Bimekizumab)

Enrolling by invitation
  • Psoriatic Arthritis
  • Phoenix, Arizona
  • +138 more
Apr 7, 2022

Hidradenitis Suppurativa Trial in Worldwide (Bimekizumab, Adalimumab, Placebo)

Completed
Has Results
  • Hidradenitis Suppurativa
  • Los Angeles, California
  • +30 more
Mar 14, 2022

Psoriatic Arthritis Trial in Worldwide (Placebo, Bimekizumab)

Completed
Has Results
  • Psoriatic Arthritis
  • San Diego, California
  • +39 more
Oct 30, 2020

Multiple Sclerosis Treated Fingolimod or Other Approved

Completed
  • Multiple Sclerosis
  • Birmingham, Alabama
  • +237 more
Dec 28, 2021

Relapsing Forms of Multiple Sclerosis Trial in Worldwide (Fingolimod)

Completed
Has Results
  • Relapsing Forms of Multiple Sclerosis
  • Cullman, Alabama
  • +457 more
Mar 26, 2021

Multiple Sclerosis Trial in Worldwide (Fingolimod)

Completed
Has Results
  • Multiple Sclerosis
  • Caba, Buenos Aires, Argentina
  • +28 more
Mar 17, 2015